Tumor Lysis Syndrome after the Administration of Ruxolitinib in a Patient with Post-polycythemia Vera Myelofibrosis

The development of tumor lysis syndrome (TLS) in association with treatment for myeloproliferative neoplasms (MPNs) is relatively rare. We herein present the case of a post-polycythemia vera (PV) myelofibrosis patient with massive splenomegaly who developed laboratory TLS after treatment with ruxoli...

Descripción completa

Detalles Bibliográficos
Autores principales: Koshiishi, Megumi, Sueki, Yuki, Kawashima, Ichiro, Nakajima, Kei, Mitsumori, Toru, Kirito, Keita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635310/
https://www.ncbi.nlm.nih.gov/pubmed/28794380
http://dx.doi.org/10.2169/internalmedicine.8706-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635310/
https://www.ncbi.nlm.nih.gov/pubmed/28794380
http://dx.doi.org/10.2169/internalmedicine.8706-16

Ejemplares similares